Megan Heft AstraZeneca

Megan Heft is Director of Device Development in Biopharmaceutical Development at AstraZeneca, where she leads device teams in development of parenteral combination products for assets ranging from early to late stage. Megan has over fourteen years of industry experience, with prior roles as device team lead in Combination Products R&D at Teva Pharmaceuticals and technical lead in Primary Container R&D at West Pharmaceutical Services. Megan holds a Master of Engineering in Biomedical Engineering from Cornell University and a Bachelor of Science in Biomedical Engineering from Bucknell University.